Abstract
Determination of drugs of abuse in blood is of great importance in clinical and forensic toxicology. This review describes procedures for detection of the following drugs of abuse and their metabolites in whole blood, plasma or serum: Δ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol, 11-nor-9-carboxy-Δ9-tetrahydrocannabinol, 11-nor-9-carboxy-Δ9-tetrahydrocannabinol glucuronide, heroin, 6-monoacetylmorphine, morphine, morphine-6-glucuronide, morphine-3-glucuronide, codeine, amphetamine, methamphetamine, 3,4-methylenedioxymethamphetamine, N-ethyl-3,4-methylenedioxyamphetamine, 3,4-methylenedioxyamphetamine, cocaine, benzoylecgonine, ecgonine methyl ester, cocaethylene, other cocaine metabolites or pyrolysis products (norcocaine, norcocaethylene, norbenzoylecgonine, m-hydroxycocaine, p-hydroxycocaine, m-hydroxybenzoylecgonine, p-hydroxybenzoylecgonine, ethyl ecgonine, ecgonine, anhydroecgonine methyl ester, anhydroecgonine ethyl ester, anhydroecgonine, noranhydroecgonine, N-hydroxynorcocaine, cocaine N-oxide, anhydroecgonine methyl ester N-oxide). Metabolites and degradation products which are recommended to be monitored for assessment in clinical or forensic toxicology are mentioned. Papers written in English between 2002 and the beginning of 2007 are reviewed. Analytical methods are assessed for their suitability in forensic toxicology, where special requirements have to be met. For many of the analytes sensitive immunological methods for screening are available. Screening and confirmation is mostly done by gas chromatography (GC)–mass spectrometry (MS) or liquid chromatography (LC)–MS(/MS) procedures. Basic information about the biosample assayed, internal standard, workup, GC or LC column and mobile phase, detection mode, and validation data for each procedure is summarized in two tables to facilitate the selection of a method suitable for a specific analytic problem.
This is a preview of subscription content, access via your institution.
Abbreviations
- AEME:
-
anhydroecgonine methyl ester
- APCI:
-
atmospheric pressure chemical ionization
- BZE:
-
benzoylecgonine
- CI:
-
chemical ionization
- CYP:
-
cytochrome P-450
- CZE:
-
capillary zone electrophoresis
- DAD:
-
diode array detection
- EI:
-
electron ionization
- EME:
-
ecgonine methyl ester
- ESI:
-
electrospray ionization
- GC:
-
gas chromatography
- HFBA:
-
heptafluorobutyric anhydride
- (S)-HFBPCl:
-
(S)-(-)-heptafluorobutyrylprolyl chloride
- HPLC:
-
high-performance liquid chromatography
- LC:
-
liquid chromatography
- LIF:
-
laser-induced fluorescence
- LLE:
-
liquid–liquid extraction
- LOQ:
-
limit of quantification
- LOD:
-
limit of detection
- 6-MAM:
-
6-monoacetylmorphine
- MDA:
-
3,4-methylenedioxyamphetamine
- MDEA:
-
N-ethyl-3,4-methylenedioxyamphetamine
- MDMA:
-
3,4-methylenedioxymethamphetamine
- M3G:
-
morphine-3-glucuronide
- M6G:
-
morphine-6-glucuronide
- MRM:
-
multiple reaction monitoring
- MS:
-
mass spectrometry
- MS/MS:
-
tandem mass spectrometry
- (R)-(-)-MTPCl:
-
(R)-(-)-α-methoxy-α-trifluoromethylphenylacetyl chloride
- NICI:
-
negative ion chemical ionization
- OH-THC:
-
11-hydroxy-Δ9-tetrahydrocannabinol
- PICI:
-
positive ion chemical ionization
- SIM:
-
selected ion monitoring
- SPE:
-
solid-phase extraction
- THC:
-
Δ9-tetrahydrocannabinol
- THC-COOgluc:
-
11-nor-9-carboxy-Δ9-tetrahydrocannabinol glucuronide
- THC-COOH:
-
11-nor-9-carboxy-Δ9-tetrahydrocannabinol
- UPLC:
-
ultraperformance liquid chromatography
References
Moeller MR, Kraemer T (2002) Ther Drug Monit 24:210–221
Chu MH, Drummer OH (2002) J Anal Toxicol 26:575–581
Kroener L, Musshoff F, Madea B (2003) J Anal Toxicol 27:205–212
Kupiec T, DeCicco L, Spiehler V, Sneed G, Kemp P (2002) J Anal Toxicol 26:513–518
Spiehler V, Isenschmid DS, Matthews P, Kemp P, Kupiec T (2003) J Anal Toxicol 27:587–591
Schutz H, Auch J, Erdmann F, Weiler G, Verhoff MA (2006) Arzneimittelforschung 56:414–420
Maurer HH (2005) Clin Biochem 38:310–318
Maurer HH (2004) Clin Chem Lab Med 42:1310–1324
Maurer HH, Peters FT (2005) Ther Drug Monit 27:686–688
European Monitoring Centre for Drugs and Drug Addiction (2006) Annual report 2006: the state of the drugs problem in Europe. Office for Official Publications of the European Communities, Luxembourg
SAMHSA (2005) 2005 National survey on drug use & health: national findings. DHHS publication no SMA 06-4194
Huang W, Moody DE, Andrenyak DM, Smith EK, Foltz RL, Huestis MA, Newton JF (2001) J Anal Toxicol 25:531–537
Gustafson RA, Moolchan ET, Barnes A, Levine B, Huestis MA (2003) J Chromatogr B 798:145–154
Steinmeyer S, Bregel D, Warth S, Kraemer T, Moeller MR (2002) J Chromatogr B 772:239–248
Giroud C, Menetrey A, Augsburger M, Buclin T, Sanchez-Mazas P, Mangin P (2001) Forensic Sci Int 123:159–164
Skopp G, Potsch L, Mauden M, Richter B (2002) Forensic Sci Int 126:17–23
Teske J, Putzbach K, Engewald W, Muller RK (2002) J Chromatogr B 772:299–306
Nadulski T, Sporkert F, Schnelle M, Stadelmann AM, Roser P, Schefter T, Pragst F (2005) J Anal Toxicol 29:782–789
Scurlock RD, Ohlson GB, Worthen DK (2006) J Anal Toxicol 30:262–266
Maralikova B, Weinmann W (2004) J Mass Spectrom 39:526–531
Yang R, Xie W (2006) Forensic Sci Int 162:135–139
Laloup M, Del Mar Ramirez FM, Wood M, De BG, Maes V, Samyn N (2006) Forensic Sci Int 161:175–179
Skopp G, Potsch L (2002) Clin Chem 48:301–306
Abbara C, Galy R, Benyamina A, Reynaud M, Bonhomme-Faivre L (2006) J Pharm Biomed Anal 41:1011–1016
Toennes SW, Kauert GF (2001) J Anal Toxicol 25:339–343
Ghazi-Khansari M, Zendehdel R, Pirali-Hamedani M, Amini M (2006) Clin Chim Acta 364:235–238
Emara S, Darwish I, Youssef D, Masujima T (2004) Biomed Chromatogr 18:21–27
Salmon AY, Goren Z, Avissar Y, Soreq H (1999) Clin Exp Pharmacol Physiol 26:596–600
Leis HJ, Fauler G, Raspotnig G, Windischhofer W (2002) J Mass Spectrom 37:395–400
Lotsch J (2005) J Pain Symptom Manage 29:S10–S24
Shou WZ, Pelzer M, Addison T, Jiang X, Naidong W (2002) J Pharm Biomed Anal 27:143–152
Rook EJ, Huitema AD, van den BW, Hillebrand MJ, van Ree JM, Beijnen JH (2006) J Anal Toxicol 30:390–394
Whittington D, Kharasch ED (2003) J Chromatogr B 796:95–103
de Jong LA, Kramer K, Kroeze MP, Bischoff R, Uges DR, Franke JP (2005) J Pharm Biomed Anal 39:964–971
Kemp P, Sneed G, Kupiec T, Spiehler V (2002) J Anal Toxicol 26:504–512
Mi JQ, Zhang XX, Chang WB (2004) J Immunoassay Immunochem 25:57–70
Ropero-Miller JD, Lambing MK, Winecker RE (2002) J Anal Toxicol 26:524–528
Meatherall R (2005) J Anal Toxicol 29:301–308
Hupka Y, Beike J, Roegener J, Brinkmann B, Blaschke G, Kohler H (2005) Int J Legal Med 119:121–128
Bengtsson J, Jansson B, Hammarlund-Udenaes M (2005) Rapid Commun Mass Spectrom 19:2116–2122
Wyman J, Bultman S (2004) J Anal Toxicol 28:260–263
Kerrigan S, Honey D, Baker G (2004) J Anal Toxicol 28:529–532
Crandall CS, Kerrigan S, Blau RL, Lavalley J, Zumwalt R, McKinney PE (2006) J Forensic Sci 51:413–420
Lewis RJ, Johnson RD, Hattrup RA (2005) J Chromatogr B 822:137–145
Leis HJ, Windischhofer W, Fauler G (2002) Rapid Commun Mass Spectrom 16:646–649
Netriova J, Blahova E, Johanesova Z, Brandsteterova E, Lehotay J, Serdt K, Mocak J (2006) Pharmazie 61:528–534
Bouwmeester NJ, Anderson BJ, Tibboel D, Holford NH (2004) Br J Anaesth 92:208–217
Peters JW, Anderson BJ, Simons SH, Uges DR, Tibboel D (2005) Intensive Care Med 31:257–263
Rook EJ, Hillebrand MJ, Rosing H, van Ree JM, Beijnen JH (2005) J Chromatogr B 824:213–221
Shou WZ, Chen YL, Eerkes A, Tang YQ, Magis L, Jiang X, Naidong W (2002) Rapid Commun Mass Spectrom 16:1613–1621
Musshoff F, Trafkowski J, Kuepper U, Madea B (2006) J Mass Spectrom 41:633–640
de la TR, Farre M, Navarro M, Pacifici R, Zuccaro P, Pichini S (2004) Clin Pharmacokinet 43:157–185
Kraemer T, Maurer HH (2002) Ther Drug Monit 24:277–289
Musshoff F (2000) Drug Metab Rev 32:15–44
de la TR, Farre M, Roset PN, Pizarro N, Abanades S, Segura M, Segura J, Cami J (2004) Ther Drug Monit 26:137–144
Peters FT, Schaefer S, Staack RF, Kraemer T, Maurer HH (2003) J Mass Spectrom 38:659–676
Kankaanpää A, Gunnar T, Ariniemi K, Lillsunde P, Mykkanen S, Seppala T (2004) J Chromatogr B 810:57–68
Nishida M, Namera A, Yashiki M, Kojima T (2003) J Chromatogr B 789:65–71
Nishida M, Namera A, Yashiki M, Kojima T (2002) Forensic Sci Int 125:156–162
Frison G, Tedeschi L, Favretto D, Reheman A, Ferrara SD (2005) Rapid Commun Mass Spectrom 19:919–927
Hidvegi E, Fabian P, Hideg Z, Somogyi G (2006) Forensic Sci Int 161:119–123
Kronstrand R, Ahlner J, Dizdar N, Larson G (2003) J Anal Toxicol 27:135–141
Slawson MH, Taccogno JL, Foltz RL, Moody DE (2002) J Anal Toxicol 26:430–437
Mortier KA, Dams R, Lambert WE, De Letter EA, Van CS, De Leenheer AP (2002) Rapid Commun Mass Spectrom 16:865–870
Nyström I, Trygg T, Woxler P, Ahlner J, Kronstrand R (2005) J Anal Toxicol 29:682–688
Apollonio LG, Pianca DJ, Whittall IR, Maher WA, Kyd JM (2006) J Chromatogr B 836:111–115
Dams R, De Letter EA, Mortier KA, Cordonnier JA, Lambert WE, Piette MH, Van CS, De Leenheer AP (2003) J Anal Toxicol 27:318–322
Hendrickson HP, Milesi-Halle A, Laurenzana EM, Owens SM (2004) J Chromatogr B 806:81–87
Segura M, Ortuno J, McLure JA, Pujadas M, Pizarro N, Farre M, Llebaria A, Joglar J, Segura J, de la TR (2002) J Chromatogr B 769:313–321
Wood M, De BG, Samyn N, Morris M, Cooper DP, Maes RA, De Bruijn EA (2003) J Anal Toxicol 27:78–87
Maurer HH (2005) Anal Bioanal Chem 381:110–118
Tomita M, Nakashima MN, Wada M, Nakashima K (2006) Biomed Chromatogr 20:1380–1385
Peters FT, Kraemer T, Maurer HH (2002) Clin Chem 48:1472–1485
Peters FT, Samyn N, Lamers CT, Riedel WJ, Kraemer T, De BG, Maurer HH (2005) Clin Chem 51:1811–1822
Peters FT, Samyn N, Wahl M, Kraemer T, De BG, Maurer HH (2003) J Anal Toxicol 27:552–559
Leis HJ, Rechberger GN, Fauler G, Windischhofer W (2003) Rapid Commun Mass Spectrom 17:569–575
Pizarro N, Llebaria A, Cano S, Joglar J, Farre M, Segura J, de la TR (2003) Rapid Commun Mass Spectrom 17:330–336
Pizarro N, Farre M, Pujadas M, Peiro AM, Roset PN, Joglar J, de la TR (2004) Drug Metab Dispos 32:1001–1007
Rasmussen LB, Olsen KH, Johansen SS (2006) J Chromatogr B 842:136–141
Buechler J, Schwab M, Mikus G, Fischer B, Hermle L, Marx C, Gron G, Spitzer M, Kovar KA (2003) J Chromatogr B 793:207–222
Rudaz S, Geiser L, Souverain S, Prat J, Veuthey JL (2005) Electrophoresis 26:3910–3920
Brzezinski MR, Abraham TL, Stone CL, Dean RA, Bosron WF (1994) Biochem Pharmacol 48:1747–1755
Kloss MW, Rosen GM, Rauckman EJ (1983) Mol Pharmacol 23:482–485
LeDuc BW, Sinclair PR, Shuster L, Sinclair JF, Evans JE, Greenblatt DJ (1993) Pharmacology 46:294–300
Pellinen P, Kulmala L, Konttila J, Auriola S, Pasanen M, Juvonen R (2000) Arch Toxicol 74:511–520
Kovacic P (2005) Med Hypotheses 64:350–356
Kovacic P, Cooksy AL (2005) Med Hypotheses 64:357–366
Cone EJ, Tsadik A, Oyler J, Darwin WD (1998) Ther Drug Monit 20:556–560
Watanabe K, Hida Y, Matsunaga T, Yamamoto I, Yoshimura H (1993) Biol Pharm Bull 16:1041–1043
Zhang JY, Foltz RL (1990) J Anal Toxicol 14:201–205
Jacob P III, Lewis ER, Elias-Baker BA, Jones RT (1990) J Anal Toxicol 14:353–357
Kintz P, Sengler C, Cirimele V, Mangin P (1997) Hum Exp Toxicol 16:123–127
Nakahara Y, Ishigami A (1991) J Anal Toxicol 15:105–109
Toennes SW, Fandino AS, Kauert G (1999) J Chromatogr B 735:127–132
Fandino AS, Toennes SW, Kauert GF (2002) J Anal Toxicol 26:567–570
Paul BD, McWhorter LK, Smith ML (1999) J Mass Spectrom 34:651–660
Paul BD, Lalani S, Bosy T, Jacobs AJ, Huestis MA (2005) Biomed Chromatogr 19:677–688
Fandino AS, Karas M, Toennes SW, Kauert G (2002) J Mass Spectrom 37:525–532
Lin SN, Walsh SL, Moody DE, Foltz RL (2003) Anal Chem 75:4335–4340
Wang PP, Bartlett MG (1999) J Anal Toxicol 23:62–66
Fernandez P, Morales L, Vazquez C, Bermejo AM, Tabernero MJ (2006) Forensic Sci Int 161:31–35
Fernandez P, Bujan L, Bermejo AM, Tabernero MJ (2004) J Appl Toxicol 24:283–287
Cardona PS, Chaturvedi AK, Soper JW, Canfield DV (2006) Forensic Sci Int 157:46–56
Alvarez I, Bermejo AM, Tabernero MJ, Fernandez P, Lopez P (2007) J Chromatogr B 845:90–94
Laizure SC, Mandrell T, Gades NM, Parker RB (2003) Drug Metab Dispos 31:16–20
Toennes SW, Fandino AS, Hesse FJ, Kauert GF (2003) J Chromatogr B 792:345–351
Kolbrich EA, Barnes AJ, Gorelick DA, Boyd SJ, Cone EJ, Huestis MA (2006) J Anal Toxicol 30:501–510
Duer WC, Spitz DJ, McFarland S (2006) J Forensic Sci 51:421–425
Gunnar T, Mykkanen S, Ariniemi K, Lillsunde P (2004) J Chromatogr B 806:205–219
Concheiro M, de CA, Quintela O, Lopez-Rivadulla M, Cruz A (2006) J Chromatogr B 832:81–89
Maralikova B, Weinmann W (2004) J Chromatogr B 811:21–30
Allen KR, Azad R, Field HP, Blake DK (2005) Ann Clin Biochem 42:277–284
Valaskovic GA, Utley L, Lee MS, Wu JT (2006) Rapid Commun Mass Spectrom 20:1087–1096
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kraemer, T., Paul, L.D. Bioanalytical procedures for determination of drugs of abuse in blood . Anal Bioanal Chem 388, 1415–1435 (2007). https://doi.org/10.1007/s00216-007-1271-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-007-1271-6
Keywords
- Drugs of abuse
- Gas chromatography–mass spectrometry
- Liquid chromatography–tandem mass spectrometry
- Blood
- Determination
- Forensic toxicology